Drug Delivery

Industry experts discuss the benefits and challenges of self-administration of injectable therapies.

A survey provides insight into drug companies' plans for spending on outsourced services. This article contains bonus online material.

Vetter held a groundbreaking ceremony for its new facility in Ravensburg.

Formulation strategy is an important consideration when selecting and managing outsourced biopharmaceutical development programs.

How to maintain product stability and prevent particulates.

The disadvantages of the traditional vaccine regime (prime plus boost) have spurred the development of single-shot vaccines. This article describes the development and manufacture of a prototype single-shot vaccine that uses microspheres made from cross-linked modified dextran polymers for controlled release of the antigen.

In new disposables projects, it is critical that engineering, procurement, and operations groups work together early on to manage supply chain risk.

The year 2007 witnessed the approval of fifteen biopharmaceuticals in the United States and European Union.

Set limits to provide incentives for process improvements.

Resolve confusion about measurements.

US Food and Drug Administration's Division of Biologic Oncology Products has approved two new biologics license application (BLA) supplements expanding the approval of Genentech's Herceptin (trastuzumab) for the treatment of breast cancer.

Nothing beats a good dictionary. It can clarify doubts, settle an argument, or prompt exploration into new areas of learning.

The transdermal delivery of biologics-as well as of conventional drugs-is growing in popularity because the technique offers numerous advantages.